12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Company News  |  Deals

Medigene, Sinphar Pharmaceutical deal

Medigene granted Sinphar's SynCore Biotechnology Co. Ltd. subsidiary exclusive rights to co-develop and commercialize EndoTAG-1 in Asia, Australia and New Zealand. SynCore will fund the Asian portion of the planned...

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >